key: cord-0438669-kp9mxswr
authors: Gavish, Nir; Katriel, Guy
title: Optimal vaccination at high reproductive numbers: sharp transitions and counter-intuitive allocations
date: 2022-02-06
journal: nan
DOI: nan
sha: 5e0fe777a886af796647fdc492ff539f70140091
doc_id: 438669
cord_uid: kp9mxswr

Optimization of vaccine allocations among different segments of a heterogeneous population is important for enhancing the effectiveness of vaccination campaigns in reducing the burden of epidemics. Intuitively, it would seem that allocations designed to minimize infections should prioritize those with the highest risk of being infected and infecting others. This prescription is well supported by vaccination theory, e.g., when the vaccination campaign aims to reach herd immunity. In this work, we show, however, that for vaccines providing partial protection (leaky vaccines) and for sufficiently high values of the basic reproduction number, intuition is overturned: the optimal allocation for minimizing the number of infections prioritizes the vaccination of those who are least likely to be infected. Furthermore, we show that this phenomenon occurs at a range of basic reproduction numbers relevant for the currently circulating strains of SARS-CoV-19. The work combines numerical investigations, asymptotic analysis for a general model, and complete mathematical analysis in a simple two-group model. The results point to important considerations in managing vaccination campaigns for infections with high transmissibility.

Vaccination is the foremost tool for reducing the burden of contagious diseases. Mathematical models describing the spread of epidemics are widely used to explore the effect of vaccination on transmission dynamics and epidemic outcomes [1] [2] [3] [4] . Heterogeneity of the population along various dimensions plays a vital role in shaping transmission dynamics. Different sub-populations, such as age groups or occupational groups, have different levels of contact among themselves and with others and may vary in their intrinsic susceptibility to being infected due to biological factors. Heterogeneity provides important opportunities for enhancing the effectiveness of vaccination campaigns by prioritizing the vaccination of some sub-populations [5] . This has led to a vast literature addressing the question of optimal vaccination in heterogeneous populations, under constraints on the number of vaccines that can be administered, with various aims, such as achieving herd immunity [6] [7] [8] [9] , minimizing the initial growth rate of an emerging epidemic [10] or minimizing epidemic outcomes -the total number of infections, morbidity or mortality [11] [12] [13] [14] [15] . These efforts have naturally received widespread attention in the wake of the COVID-19 pandemic [16] [17] [18] [19] [20] [21] . Yet, while most studies of optimal vaccination have involved transmission at relatively low reproduction numbers, e.g., associated with Influenza, often within the range of values for which herd immunity can be achieved, recent lineages of SARS-CoV-19 are associated with high reproduction numbers (R 0 ) [22] [23] [24] . In this work, we show that high R 0 can lead to a dramatic and surprising change in the optimal allocation of vaccines.

We consider here the problem of optimal distribution of a leaky vaccine -one providing partial protection -to a heterogeneous population, to minimize the total number of infections during an epidemic. Figure 1 : Example with three groups. Individuals of each of the groups interact with those of all other groups (random mixing), but members of group 2 (50% of the population) have twice as many daily interactions as members of group 1 (25% of the population), and members of group 3 (25% of the population) have twice as many interactions as members of group 2. We consider the optimal allocation of vaccine to 40% of the population, where vaccine efficacy in blocking transmission is 80%. Graph presents the optimal vaccine allocations as a function of R 0 . At sufficienly high R 0 it is optimal to vaccinate the entire low-contact group, with the remaining vaccines allocated to the medium contact group so that the high contact group is left entirely non-vaccinated.

We first demonstrate this claim using a simple example that considers a population subdivided into three subpopulations differing by their number of daily contacts: low-contact, medium-contact, and high-contact groups, but with homogeneous mixing among all individuals. Figure 1 shows the optimal allocation for minimizing the number of infections for a given vaccine coverage 1 , in dependence on the reproductive number R 0 . As expected, for lower values of R 0 (R 0 < 4.7), the optimal allocation covers the entire high-contact group, with the remaining vaccines allocated to the medium-contact group. However, for R 0 > 5.8 it is optimal to vaccinate the entire low-contact group, with the remaining vaccines allocated to the medium contact group so that the high contact group is left entirely nonvaccinated! This 'paradoxical' effect, whereby it is sometimes optimal to vaccinate those less prone to infection while leaving those more prone to infection unprotected, is the focus of this work.

At an intuitive level, the seemingly paradoxical optimal allocation of vaccines to those who are at lower risk of being infected can be understood as follows: for sufficiently high R 0 , breakthrough infections among those who are more prone to infection become so common that it becomes inefficient to allocate vaccines to those groups. Instead, the optimal strategy is to move to a second line of defense and vaccinate sub-populations that are less prone to infection.

We further claim that the transition to infections-minimizing allocations which prioritize those who are least prone to infection occurs for values of the parameter R 0 which are relevant to SARS-CoV-19. To demonstrate this point, we present a more realistic example computed using an age-structured transmission model with the estimated contact matrix for the USA. We assume that the susceptibility of children younger than 10 is 50% lower than that of older individuals, following estimates for SARS-Cov-19 [25] [26] [27] . In this case, we observe that for values of R 0 > 6, it becomes optimal to allocate vaccines to those of age 60 and older, despite their lower number of contacts, and to children under 10, despite their lower susceptibility, at the expense of vaccine allocation to those who contribute most to the spread of disease, see Figure 2 . We have considered various scenarios in eight other countries and observed similar results.

The analytical results presented in this work rigorously characterize the phenomenon illustrated by the above examples and show that it is generic. Our key result considers the general case of a population divided into n groups, with a general structure of contacts among the groups, and uses asymptotic analysis to obtain an explicit vaccine allocation which is nearly optimal for large R 0 . The nearly-optimal allocation (i.e., optimal up to an exponentially small error) is to administer vaccines to those who are least prone to infection, as determined by an exposure index 1 See the figure's caption for details on the parameters in this example Infections minimizing vaccine allocations -USA example 10 Figure 2 : Example using the USA demographic and social structure. Optimal vaccine allocations for minimizing the overall number of infections for vaccine coverage of 55% of the population with vaccine efficacy of 80% in blocking transmission. For low values of R 0 , vaccination of spreaders is the best way to minimize the overall number of infections. However, for R 0 > 6, it becomes optimal to allocate vaccines to the elderly, at the expense of vaccine allocation to those who contribute most to spreading.

which is computed for each group as a weighted sum of the number of interactions made by members of that group.

In the example presented in Figure 2 , the theoretical 'nearly-optimal' allocation in fact coincides with the optimal allocation for R 0 > 7.5.

To obtain a more refined theoretical understanding of the phenomena of interest, we also consider a minimal case of two groups with different susceptibilities, which is amenable to complete mathematical analysis. In this case, we prove the existence of a critical threshold R * 0 at which a sharp transition occurs in the optimal allocation, from vaccinating those who are more susceptible to an allocation which prioritizes those who are less susceptible.

We consider optimal allocation of vaccines, using a standard SIR model (7)-(10), in which the population is subdivided into n groups, with N j the fraction of population in group j. Thus, n j=1 N j = 1. The asymptotic analysis of vaccine allocations at high R 0 gives rise to a quantity e j associated to each group j, which we refer to as the exposure index of members of the group:

Here, C jk is the mean number of contacts of a single member of group j with members of group k per unit time, σ j is the susceptibility of members of group j relative to those of group 1, and η j is the infectivity of members of group j relative to those of group 1 (thus σ 1 = η 1 = 1). We remark that the quantities e j can be interpreted as proportional to the probabilities per unit time of an individual of group j to be infected, assuming this individual is placed in a population all of whose members are infected. We assume a vaccine provides imperfect leaky protection [28] , reducing susceptibility by a factor ε ∈ (0, 1) (thus 1 − ε is the vaccine efficacy). Vaccination is performed before the introduction of the pathogen. Vaccine allocation is defined by a vector v whose components 0 ≤ v j ≤ N j , are the fractions of the population in groups j = 1, · · · , n which are vaccinated. The final size of the epidemic is computed as the solution of a standard final size equation (FSE) system, see (12) . We control the reproductive number R 0 by varying the transmission parameter β, keeping all other parameters fixed, and denote the final size by Z(R 0 , v). To find the allocation minimizing the final size, given the total coverage v, we solve the optimization problem

The following result shows that for sufficiently high values of R 0 , prioritizing the vaccination of the groups with lowest exposure index provides a nearly-optimal vaccine allocation. Theorem 1. Assume, without loss of generality, that the groups are ordered in non-decreasing order of their exposure indices given by (1), e 1 ≤ e 2 ≤ · · · ≤ e n .

Then, for given vaccine coverage v, the vaccine allocation

where j * is the maximal index for which j * k=1 N j ≤ v, gives rise to a nearly minimal final size (overall number of infections) in the sense that, defining v optimal to be a minimizer of (2), we have, for some c > 0,

Proof: See Section 5.3 and Appendix A. The example given in Figure 2 illustrates the results of Theorem 1, using parameters corresponding to the USA demography and contact structure [29] with nine 10-year age groups, and with an age-dependent susceptibility profile for SARS-CoV-19 in which the susceptibility of children is reduced [25] . Under these conditions, age group 0-9 has the smallest exposure index, followed by, with increasing exposure index, age groups 70-79, 80+, 10-19, 40-49, 60-69, 50-59, and 20-29. Finally, the age group 30-39 has the largest exposure index. Accordingly, in this case, by Theorem 1, for sufficiently high R 0 , it is (essentially) optimal to first allocate all vaccines to age group 0-9, and then, based on the availability of supply, v, to extend coverage to age groups 70-79, 80+, 10-19, 40-49, 60-69, and so on. Figure 2 presents the optimal infection minimizing vaccine allocations as a function of R 0 in the case vaccine efficacy in preventing infections is 80%. For R 0 7.5, we observe that the computed optimal allocation coincides with the asymptotic allocation v * , defined in (3) in Theorem 1. Among the age groups included in this vaccine allocation, age group 60-69 has the highest exposure index. Therefore, by Theorem 1, a gradual decrease of the overall vaccine coverage will lead to a reduction in vaccines allocated to age group 60-69 until this age group is completely removed from the optimal allocation (data not shown). Figure 3 presents the attack rates corresponding to different allocations of vaccines, in dependence on R 0 , for the same example as in Figure 2 . It is interesting to observe that although the asymptotic allocation v * given by (3) coincides with the optimal allocation only for R 0 7.5, see Figure 2 , already for R 0 > 5.7 the attack rate corresponding to the asymptotic allocation is very close to the attack rate corresponding to the optimal allocation. Indeed, for R 0 > 5.7 the relative error E defined by (4) is less than 1%. Furthermore, in this regime of R 0 , the asymptotic allocation v * performs much better than common allocations considered in the literature such as the uniform allocation or allocation of vaccines to those which are most prone to become infected. We have performed similar computations using contact matrices estimated for different countries, different levels of vaccine efficacy and coverage, finding that the minimal values of R 0 for which the relative error E is less than %1 fall in the range 4 < R 0 < 10 with mean R 0 ≈ 6, see Appendix C. We therefore conclude that the asymptotic allocation given by Theorem 1 is nearly optimal for parameter values which are relevant to some lineages of SARS-CoV-19.

In this section, we consider a minimal model allowing us to study how optimal vaccine allocations change with the reproductive number -the simplicity of the model enables us to obtain a complete mathematical analysis of the Figure 3 : Attack rate as a function of R 0 for different allocations. The attack rate (percent of those infected among the population) as a function of R 0 for the example presented in Figure 2 . Dashed-dotted blue curve corresponds to the optimal allocation at R 0 = 2.6, see Figure 2 , which prioritizes those who contribute to the spread of the disease. The solid red curve corresponds to the asymptotic allocation v * , see (3), dashed black curve corresponds to the optimal vaccine allocation for minimizing infections, and dotted green curve corresponds to a uniform allocation of vaccines.

phenomena of interest. In this model, the population is composed of two sub-populations (e.g., age groups) with fractions N 1 , N 2 (N 1 + N 2 = 1), which differ only in their susceptibility to infection, with the susceptibility of group 2 to infection higher than that of group 1 by a factor σ > 1. Homogeneous mixing among all individuals is assumed. Accordingly, the exposure index of group 1 equals e 1 = 1, and it is smaller than the exposure index e 2 = σ > 1. We assume a vaccine provides partial leaky protection with efficacy 1 − ε.

The dynamics of spread is described by the two-group SIR model

where S i (t), V i (t) denote the size of the non-vaccinated and vaccinated parts of the population with lower (i = 1) and higher (i = 2) susceptibility (exposure index), and I(t) denotes the size of the population infected at time t, all as fractions of the total population, β is the transmission rate, and γ −1 is the duration of infectivity.

We assume that the amount of available vaccine is sufficient to vaccinate a fraction v of the population prior to the start of an epidemic. We divide this fraction into two parts v 1 , v 2 with v 1 + v 2 = v, to be administered to each of the groups. For conciseness, we will assume below that v < min(N 1 , N 2 ), that is the amount available vaccine is insufficient to vaccinate any of the two groups entirely -analogous results can be proved in the cases in which it is possible to fully vaccinate one of the two groups. Our initial conditions are thus

Our aim is to choose v 1 , v 2 so as to minimize the fraction of population Z = Z(v 1 , v 2 ) which will be infected during the epidemic. This fraction is given (in the limit of a small initial fraction of infected individuals, I 1 (0), I 2 (0) → 0) as the solution Z of the final size equation

and our optimal allocation problem is

Analyzing the above problem, we obtain

0 then the optimal solution of (6) is given by (v 1 , v 2 ) = (v, 0). The transition value R * 0 is given explicitly by the formula

where α is the unique solution of the equation

Thus it is always optimal to allocate the entire stock of vaccines to only one of the groups, but there is a switch between vaccinating the more susceptible population, i.e., group 2, when R 0 is low to vaccinating the less susceptible population, i.e., group 1, when R 0 is high.

A numerical example illustrating the contents of Theorem 2 is given in Figure 4 . This figure reveals why the op- Figure 4 : Example of two groups with different susceptibilities. The two groups are of equal size, one of which is 50% as susceptible as the other. 40% of the population can be vaccinated, with a vaccine that is 80% effective in blocking transmission. The graph presents final sizes as a function of the basic reproduction number resulting from the allocation of vaccines to those of higher susceptibility (red curve), lower susceptibility (blue curve), and the optimal allocation (black dashed curve).

timal vaccine allocation changes abruptly from allocations prioritizing the more susceptible to allocations prioritizing the less susceptible. Indeed, at low values of R 0 , the epidemic final size resulting from allocations prioritizing the more susceptible is lower than that resulting from vaccinating the less susceptible. However the final size curves intersect at the point R crit 0 , which is the point at which optimal allocation shifts to the more susceptible group. To prove Theorem 2 one must also show that allocating some of the vaccine to each of the groups is always inferior to one of the extreme allocations reserving the entire stock of vaccines to only one group, see Appendix B.3.

The results in this work reveal phenomena that have not been described in previous literature, to the best of our knowledge. These phenomena are relevant to circulating and plausibly to future lineages of SARS-CoV-19. They are also of theoretical importance, allowing us to refine our intuitions in thinking about the allocation of vaccines. Therefore, we believe the results should be of interest to researchers and public health experts involved in vaccination policies.

We have considered vaccination of a heterogeneous population, employing a vaccine that reduces the risk of infection (leaky vaccine), with the aim of minimizing the number of infections, and have shown that the optimal allocation of vaccines displays a quite complicated dependence on the reproductive number R 0 , with continuously varying rates in some intervals, constant allocation in others, and discontinuous shifts. In particular, for sufficiently large R 0 the optimal vaccine allocation has the counter-intuitive feature of favoring allocation of vaccines to the groups which are less prone to infection, as measured by the exposure indices. We have justified this result analytically, by means of an asymptotic approximation which shows that for sufficiently large values of R 0 the allocation of vaccines to the groups with lower exposure indices result in a nearly-optimal allocation. Moreover, strongly supported by numerical results, we make the following Conjecture 1. For sufficiently large R 0 the optimal allocation v optimal solving (2) coincides with the asymptotic allocation v * given by (3) .

We have rigorously proved this conjecture in the two-group case considered in Theorem 2. The proof of this conjecture in the general case remains an interesting challenge.

We note that our results hinge on the leaky nature of vaccines. For example, in the explicit two-group example, the transition value R * 0 , at which it becomes advantageous to vaccinate the less susceptible group, goes to infinity in the limit ε → 0 of perfect vaccine protection. Therefore, optimal allocations of perfect vaccines or of all-or-none vaccines will not undergo sharp transitions at high R 0 .

It should be stressed that the phenomena which have been revealed are not merely theoretical curiosities, as our numerical examples show they occur for realistic parameter values, in particular for basic reproductive numbers, vaccine efficacy, and coverage values which are in the ranges relevant for the currently circulating strains of SARS-CoV-19.

A salient characteristic of the epidemiology of COVID-19 and other infectious diseases is the fact that the risk of severe disease and mortality is strongly age-dependent. In considering the allocation of vaccines, this fact has led to an apparent trade-off between minimizing mortality by direct protection of older age groups which are at higher risk of severe outcomes and minimizing the number of infections by vaccinating younger age groups who play a larger role in the spread of infection [30] [31] [32] . An interesting consequence of the results presented here is that, for sufficiently high values of R 0 , such a trade-off does not exist, since the optimal allocation for minimizing infections, covers the older age groups, because of the fact that they are less prone to infection. Under such conditions, prioritizing older age groups is optimal both for minimizing mortality and for minimizing the number of infections.

While the focus here on prophylactic vaccine allocations that are optimal with respect to the overall number of infections, the methods, and the results can be modified to address optimization of other outcomes, such as severe cases and mortality, by weighing the infections in different age groups and according to vaccination status with appropriate rates of severe disease and mortality. In a different direction, it is also of interest to consider measures such as the peak number of daily cases during the epidemic, as this measure relates directly to the load on healthcare providers. We have found parameter regimes with high basic reproduction numbers for which vaccination of sub-populations that are least prone to infection gives rise to a lower peak number of cases compared to vaccine allocations prioritizing sub-populations that drive the epidemic spread. These results will be presented elsewhere.

From a public health point of view, the sharp transition in optimal vaccine allocation to prioritization of subpopulations that are least prone to infection stems from the fact that breakthrough infections among those who are more prone to infection become so common that it becomes less effective to allocate vaccines to those groups. Therefore, the sharp transition reflects a withdrawal to a second line of defense. We stress that an alternative policy to be considered is to apply non-pharmaceutical interventions to reduce the effective reproduction number to a level that enables avoiding such a withdrawal. More generally, it is important to be aware of the fact that the most effective allocation of public health resources to alleviating the burden of epidemics, e.g., quarantine policy, green passes, screening tests, and messaging to the public, may vary with the reproductive number, so that emergence of a variant with higher transmissibility requires a re-evaluation of existing policies. Fraction of the population in group j. C jk

The mean number of contacts of a single member of group j with members of group k per unit time. We denote by C the n × n matrix with elements

The susceptibility of members of group j relative to those of group 1 (thus σ 1 = 1). η j

The infectivity of members of group j relative to those of group 1 (thus η 1 = 1). β

Transmission parameter: the probability of infection of a non-vaccinated individual in group 1 upon contact with a member of group 1. γ

The recovery rate so that 1 γ is the mean duration of infectivity. v j ∈ [0, 1]

The fraction of the population in group j which is vaccinated.

Vaccine efficacy against infection, so that ε is the factor by which the probability of infection upon contact is reduced for those vaccinated.

All relevant data are within the manuscript, or on Zenodo at https://doi.org/10.5281/zenodo.5984404. The source code is available on GitHub at https://github.com/NGavish/HighR0.

We consider an SIR model in which the population is subdivided into n groups. The dynamic variables Sj ,Ij,Rj and Vj are the fractions of the total population consisting of susceptible, infected, recovered, and vaccinated individuals in group j, respectively. Model parameters are summarized in Table 1 . The dynamics is described by the differential equation system

where

Since a proportion vj of group j is vaccinated, we have

The basic reproductive number R0 is equal to the spectral radius of M = β γ D [33, 34].

We will denote the attack rate by Z = m j=1 zj, where zj is the fraction of the total population which consisting of individuals of group j who become infected. The quantities zj (1 ≤ j ≤ n) are obtained as solutions of a system of final size equations

Our asymptotic analysis yields the following Lemma 1. We have, for some c > 0,

where ej (1 ≤ j ≤ n) are the exposure indices defined by (1).

This approximation suggests the consideration of the following optimization problem

as an approximation to the problem (2). The advantage of (13) is that it is a simple linear optimization problem. Indeed, it is immediate that to maximize (13) we need to allocate as much of the total vaccine available to those groups j for which the coefficients are largest, which are precisely those for which the exposure indices ej is lowest, leading to the allocation (3). Lemma 1 then leads to the conclusion that the allocation (3) is indeed nearly optimal, as expressed by (4), see Appendix A.4.

We solve the optimization problem defined in (2) using Matlabs' fmincon nonlinear programming solver. The examples presented in the manuscript involve a computation of solutions of the optimization problem for a range of basic reproduction numbers R0. To do so, R0 is gradually increased, so that the initial guess used for basic reproduction number R0 +δR is the optimal allocation computed for the basic reproduction number R0. To reduce the probability of convergence to a local minimum, we also repeatedly randomized the initial allocation provided to the iterative algorithm and verified that it converges to the same minimum so, that we are reasonably confident that we have found the global minima.

In all example presented in the manuscript, we consider 80% vaccine efficacy against infections, i.e., ε = 0.2, and a uniform infectivity profile ηi = 1 for all groups. We note that the expressions for the reproductive number, as well as in the final size equations, depend on β/γ. Therefore we do not need to fix a value for the parameters β and γ separately, but rather adjust the value of β/γ to achieve the desired value of R0.

The three group example presented in Figure 1 considers a case in which individuals of group 1 (25% of the population) interact half as frequently as those in group 2, and individuals of group 3 (another 25% of the population) interact twice as frequently as those in group 2. Therefore, the group size parameters are N = (0.25, 0.5, 0.25), the corresponding contact matrix is The example using the USA demography and social structure presented in Figure 2 uses the following parameters:

• Age Demographics were taken from the UN World Population Prospects 2019 for each country [35] , using n = 9 age groups, of sizes Nj (1 ≤ j ≤ 9) corresponding to 10-year increments, with the last group comprising those of age 80 and older.

• Contact matrix C = {C jk } n j,k=1 was taken from [29] . Age bins in each case were originally provided in a 5-year increment, where the last age bin corresponds to ages 75 and older. We follow the procedure as in [18] to adapt the matrices into 10-year increments.

• Relative susceptibility parameters σi are taken from the age dependent relative susceptibility profile for SARS-CoV- 19 from [25] : (σ1, · · · , σ9) = (1, 0.95, 1.975, 2.15, 2, 2.05, 2.2, 1.85, 1.85),

in which the relative susceptibility of age group 0-19 is roughly half those of older age groups.

The parameters used in the two group example presented in Figure 4 are

A Vaccination at high R 0 : proofs

The final-size formula yields the overall number of infections in each group in terms of the model parameters [33, 34] . We derive the final size formula corresponding to the above model. From (7) and (8) we have

which upon integration yields

Summing (7)-(9), we have

Since Sj(t) + Vj (t) + Ij(t) + Rj(t) = Nj for all t, and Ij (∞) = 0, we have

and can write (15) as

so that (14) yields

Combining (16) and (17) yields

or, defining zj = Rj (∞) − Rj (0) to be fraction of the population consisting of individuals of group j infected throughout the post-vaccination period:

Assuming that Rj (0) = 0 (no unvaccinated individuals are initially immune), Ij(0) = 0 (the initial fraction of infected individuals is very small) and setting Vj(0) = vj , we have

The total number fraction of the population infected is then

zj.

We note that in the particular case of homogeneous mixing and identical infectivity of all groups, we have

where c is the average number of contacts per individual, and summing the n equations (18), we obtain

This gives in particular the final-size equation (5) for two groups with varying susceptibility, used in section B, where c is absorbed into β.

We consider the final size Z = n j=1 zj, where zj are given as the solutions of system of final size equations given by (19) . Although our main interest is to study behavior of (19) in the regime of large basic reproduction numbers, the final size equations are not unique functions of R0. Instead, we choose to study the asymptotics of the final size for high transmission rate β since the transmission rate is proportional to the basic reproduction number and since the dependence of (19) on β is explicit. To emphasize the dependence of the final size on the transmission rate β and the vaccine allocation v = (v1, · · · , vn), fixing all other parameters, we write Z = Z(β, v). We denote the set of possible allocations by

The following asymptotic result (Lemma 1 in the main text) is the key to obtaining an approximately optimal allocation for large R0.

Lemma 2. We have, for some c > 0,

uniformly in v ∈ V, where ej (1 ≤ j ≤ n) are the exposure indices defined by

To prove this lemma we consider the solution zj = zj (β) (1 ≤ j ≤ n) of the system (19) as functions of the transmission parameter β, fixing all other parameters:

Since z k (β) → Nj as β → ∞, the right-hand side is exponentially small in β, hence, setting

we have, for some c > 0,

We re-write (24) in the form

By (25), (26) we have, as β → ∞,

Therefore, A. 3 The approximately optimal allocation for large R 0

Our optimization problem is to minimize the number infections by allocating vaccines to a given fraction v of the population:

where V is given by (21) . Motivated by Lemma 2, we introduce the approximate optimization problem

This is a linear optimization problem whose solution is immediate: assuming, without loss of generality, that the groups are ordered in non-decreasing order of their exposure index e1 ≤ e2 ≤ · · · ≤ en, the solution v * of (29) prioritises groups with low exposure index, that is

where j * is the maximal index for which j * k=1 Nj ≤ v. Theorem 1 in the main text justifies the claim that v * is a nearly-optimal solution of (28). We now prove this theorem.

Assuming v optimal is a minimizer of (28), we have, substituting v = v optimal into (22) , and using the fact that v * is the maximizer of (29),

Substituting

Combining (31), (32) we have

On the other hand, by the definition of v optimal we certainly have

which combined with (33), yields

which is equivalent to Eq. 4 in Theorem 1 of the main text.

B The two-group example: proofs

In this section we consider the two-group example

with σ > 1 (group 2 is more susceptible), and initial conditions

the reproductive number corresponding to this model (without vaccination) is

The post-vaccination reproduction number is then

so that herd immunity can be achieved and the epidemic can be prevented if Rvac ≤ 1. It is immediate from the above expression that the lowest value of Rvac will be achieved if all vaccines are allocated to the more susceptible group: v1 = 0, v2 = v, giving Rvac = R0 1 − ·vσ(1−ε) N 1 +σN 2 , so that herd immunity will be achieved if

In case herd immunity cannot be achieved, our aim is to chose v1, v2 so as to minimize the fraction of population Z = Z(v1, v2) which will be infected during the epidemic. This fraction is given by the final size equation

This is a special case of the final size equation for n groups, see (20) . We consider the problem of minimizing the final size,

In this case we can perform a complete analysis of the problem, to show how the optimal allocation shifts from the more susceptible to the less susceptible group as R0 crosses a threshold, as described in (Theorem 2 of the main text):

Assuming v < min(N1, N2), there exists a value R * 0 such that (i) If R0 < R * 0 then the optimal solution of (38) is given by (v1, v2) = (0, v). (ii) If R > R * 0 then the optimal solution of (38) is given by (v1, v2) = (v, 0). The transition value R * 0 is given explicitly by the formula

where α is the unique solution of the equation

This section is devoted to the proof of this theorem 3.

We will first compare the two options in which the entire supply of vaccine is allocated to one of the groups, showing that allocating all the vaccine to the more susceptible group is the superior option when R0 < R * 0 and the inferior option when R0 > R * 0 . Later, in Section B.3, we will show that no mixed option is better than these two extreme options.

For i = 1, 2, let Zi(r) be the attack rate in case all the vaccine is allocated to group i, in dependence on r, and assuming all other parameters are fixed. Then, using (37) with (v1, v2) = (v, 0) and (v1, v2) = (0, v), respectively, we have f1(Z1(r)) = Z1(r),

f2(Z2(r)) = Z2(r),

where

We note some basic properties of the functions f1, f2, to be used below.

(iii) For i = 1, 2: when r > ri we have

(iv) r1 < r2.

Proof. Define hi(Z) = fi(Z) − Z (i = 1, 2). hi(Z) is concave and satisfies hi(0) = 0, hi(1) < 0, so that hi(Z) = 0 has a unique solution Zi(r) ∈ (0, 1) if and only if h ′ i (0) > 0, which is equivalent to the condition r > ri. To obtain (iii) note that when r > ri, hi(Z) is positive for Z > 0 small, while hi(1) < 0. Since the only point in (0, 1) at which hi vanishes is Z = Zi(r) we conclude that hi(Z) > 0 for Z ∈ (0, Z1(r)) and hi(Z) < 0 for Z ∈ (Z1(r), 1), which gives (43). Finally, (iv) follows by direct calculation, using the definitions of r1, r2 and the assumption that σ > 1.

Note that when r ≤ ri, we have Zi(r) = 0, that is an epidemic is averted by allocating the vaccine to group i. Thus if r ≤ r1 then Z1(r) = Z2(r) = 0, hence herd immunity can be reached by allocating the vaccine to either one of the two groups, and when r1 < r ≤ r2 we have Z1(r) > 0, Z2(r) = 0, hence for r in this range one should certainly vaccinate the more susceptible group 2, and thus attain herd immunity. We are interested in the case r > r2, which is equivalent to R0 > R crit 0 (see (36) above), so this will condition will be assumed below.

Lemma 4. Assume r > r2. Define κ = κ(σ, ε) by κ = ln 1 α where α is the (unique) solution of (40). Then f1(Z) > f2(Z) when 0 < Z < κ r and f2(Z) > f1(Z) when Z > κ r .

We first prove that the equation g(x) = 0 has a unique solution α ∈ (0, 1), and that

We have g(0) = g(1) = 0 and, since

implies g(x) > 0 for x < 1 sufficiently close to 1. Therefore there exists α ∈ (0, 1) with g(α) = 0, that is a solution of (40). We now show that this solution is unique, and hence that (46) holds. Note that (40) is equivalent to

Assume by way of contradiction that h(x) = 1 has two solutions in (0, 1), in addition to the solution x = 1. Then, by Rolle's theorem, the function

has at least two zeros in (0, 1), and multiplying both sides by x 2−σε , the function

has at least two zeros in (0, 1), hence, again by Rolle's theorem, the function

has at least one zero x ∈ (0, 1). But this implies

hence, in view of the assumptions σ > 1, ε ∈ (0, 1),

contradicting the assumption σ > 1.

Noting now that we have

and similarly rZ > κ implies f1(Z) < f2(Z).

Lemma 5. Let α be the unique solution of (40), κ = ln 1 α , and

Then we have: r2 < r < r * ⇒ Z2(r) < Z1(r) r > r * ⇒ Z1(r) < Z2(r)

Proof. We claim that r1 < r < r * ⇒ Z1(r) < κ r ,

To see this, consider the function φ(r) = rZ1(r). Since Z1(r) is increasing in r, φ(r) is also increasing, and we have φ(r1) = 0 and φ(r) → ∞ as r → ∞. Therefore there is a uniquer > r1 satisfyinḡ

Since f1(Z1(r)) = Z1(r) we have

Substituting (49) in (50) gives

so we have thatr = r * as defined by (47). We have thus shown that φ(r * ) = κ, and by monotonicity of φ(r), we obtain (48). Now if r2 < r < r * then Z1(r) < κ r , so by Lemma 4 we have Z1(r) = f1(Z1(r)) > f2(Z1(r)), which, by Lemma 3(iii), implies Z2(r) < Z1(r). Similarly if r > r * we get Z2(r) > Z1(r).

In view of Lemma 5 we have, defining

that vaccinating the more susceptible group 2 is preferable if R0 < R * 0 , while vaccinating group 1 is preferable if R0 > R * 0 . Using (40), R * 0 can also be written as

.

The proof of Theorem 3 will be completed by showing that no mixed vaccination schedule outperforms the two possibilities considered above.

We now analyze the optimization problem defined in (38) and show that the solution is necessarily a boundary solution: either (v1, v2) = (v, 0) or (v1, v2) = (0, v). We reformulate the problem as a one-dimensional problem by setting

and we wish to show that ζ(v1) is maximized either at v1 = 0 or at v1 = v. We will in fact prove:

Lemma 6. Let r * be defined by (47). Assume r > r2. Then: (i) If r = r * then ζ ′ (v1) = 0 for all v1 ∈ (0, v), so that ζ(v1) is maximized either at v = 0 or at v = v1.

Proof. Note that the assumption r > r2 implies that ζ(v1) ∈ (0, 1) for all v1 ∈ [0, v] (herd immunit cannot be achieved).

(i) Let us assume, that ζ ′ (v * 1 ) = 0 for some v * 1 ∈ (0, v), and show that r = r * . Substituting v2 = v − v1 in (37) we have, for v1 ∈ [0, v],

and differentiating this relation with respect to v1 leads to

Thus, for v * 1 satisfying ζ ′ (v * 1 ) = 0 we obtain

On the other hand, substituting v1 = v * 1 in (51), we have

which, together with (52) gives

Note that (52) is equivalent to

where g(x) is defined in (45). Since in the proof of Lemma 4 we obtained that g has a unique root α = e −κ(σ,ε) , we see that for

Substituting (54) into (53) gives

so we have shown that r = r * is the unique value of r of which ζ(v1) can have a critical point v * 1 ∈ (0, 1). (ii) Now we assume that r = r * and will show that ζ(v1) = κ r * for all v1 ∈ (0, v). Indeed, by (51), ζ(v1) is the unique solution of

so it suffices to show that (55) holds identically when we substitute ζ(v1) = κ r * , that is to show

By (47) we have κ r * = 1 − (N1 − v)e −κ − N2e −σκ − ve −εκ , so (56) is equivalent, after some simplification, to e −κ − e −σκ − e −εκ + e −σεκ = 0,

which holds due to the fact that α = e −κ is the solution of (40). We have therefore proved (55), finishing the proof of (ii).

Our proof of Theorem 3 is thus complete.

We define the threshold value R threshold as the minimal value of R0 at which the relative error in the number of survivors (those not infected),

resulting from the asymptotic allocation v * , see (30) , and the computed optimal allocation v optimal is smaller than 1%. In the two group example considered in Theorem 3, the transition value R * 0 which is closely related to R threshold is given explicitly by (39). (39) implies that R * 0 increases both with vaccine efficacy and with vaccine coverage, see also Fig 5. In Fig 6  we consider more general cases and compute R threshold for various countries. As in the example of the USA in the main text ( Fig  2) , age demographics for each country were taken from the UN World Population Prospects 2019 [35] , using nine age groups, of sizes Nj (1 ≤ j ≤ 9) corresponding to 10-year increments, with the last group comprising those of age 80 and older. The contact matrices were taken from [29] and adapted to 10-year increments [18] . In all cases, we used the age dependent relative susceptibility profile for SARS-CoV-19 from [25] . In the USA example presented in Fig 2 of the main text with vaccine of efficacy of 80% and vaccine coverage of 55%, R threshold ≈ 5.7. For this choice of parameters, we observe quite small variability of R threshold among different countries with values ranging from 5 to 5.75 and a mean of 5.4. Fig 6A presents R threshold also for vaccine efficacy of 70% and 90%. As expected, R threshold increases with an increase in vaccine efficacy: The average R threshold changes from 5.4 at a vaccine efficacy of 80% to R threshold ≈ 4.3 when vaccine efficacy is 70%, and to R threshold ≈ 8 when vaccine efficacy is 90%. We again observe quite small variability of R threshold among different countries.

We further consider the dependence of R threshold on vaccine coverage. We find that the mean value of R threshold for a range of vaccine coverage values between 40% to 70% is R threshold ≈ 6 where most values lie in the range 4.25 < R threshold < 9.5. In addition, outliers with R threshold ≈ 12 are observed, see Fig 6B. Contrary to the behavior of R * 0 in the two group example, we find only weak correlation between R threshold and vaccine coverage values. This points to the complexity of the solution structure. 

Mathematical models of vaccination

Herd immunity: basic concept and relevance to public health immunization practices

Herd immunity: history, theory, practice

Infectious diseases of humans: dynamics and control

Epidemiological models for heterogeneous populations: proportionate mixing, parameter estimation, and immunization programs

Stochastic multitype epidemics in a community of households: estimation and form of optimal vaccination schemes

The critical vaccination fraction for heterogeneous epidemic models

The most efficient critical vaccination coverage and its equivalence with maximizing the herd effect

Effect of population heterogeneity on herd immunity and on vaccination decision making process

Optimizing infectious disease interventions during an emerging epidemic

Optimal but unequitable prophylactic distribution of vaccine

Mathematical analysis of a measles transmission dynamics model in bangladesh with double dose vaccination

Optimizing influenza vaccine distribution

A comparative analysis of influenza vaccination programs

Model-based reconstruction of an epidemic using multiple datasets: understanding influenza a/h1n1 pandemic dynamics in israel

Vaccine optimization for covid-19: Who to vaccinate first?

Age-targeted dose allocation can halve covid-19 vaccine requirements. medRxiv

Model-informed covid-19 vaccine prioritization strategies by age and serostatus

Evaluation of the united states covid-19 vaccine allocation strategy

Vaccination and non-pharmaceutical interventions for covid-19: a mathematical modelling study. The Lancet Infectious Diseases

The role of childrens' vaccination for covid-19 -pareto-optimal allocations of vaccines. Accepted for publication in PLOS computational biology

Omicron variant and booster covid-19 vaccines. The Lancet Respiratory Medicine

The reproductive number of the delta variant of sars-cov-2 is far higher compared to the ancestral sars-cov-2 virus

Estimating the reproductive number r0 of sars-cov-2 in the united states and eight european countries and implications for vaccination

Age-dependent effects in the transmission and control of covid-19 epidemics

The role of children in the spread of covid-19: Using household data from bnei brak, israel, to estimate the relative susceptibility and infectivity of children

On the effect of age on the transmission of sars-cov-2 in households, schools, and the community

Design and analysis of vaccine studies

Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the covid-19 era

Vaccinating the oldest against covid-19 saves both the most lives and most years of life

Transmission dynamics are crucial to covid-19 vaccination policy

Age prioritization for covid-19 vaccination does save lives and years of life

Mathematical epidemiology of infectious diseases: model building, analysis and interpretation

Modeling infectious diseases in humans and animals

United nations department of economic and social affairs population division